Close X
Saturday, November 16, 2024
ADVT 
National

Officials face battle of confidence in AstraZeneca

Darpan News Desk The Canadian Press, 16 Mar, 2021 05:53 PM
  • Officials face battle of confidence in AstraZeneca

Federal officials are mounting a renewed push to instill Canadian confidence in Oxford-AstraZeneca’s COVID-19 vaccine, but observers predict they're in for a tough battle.

Members of the federal body tasked with advising the country on vaccine use took the unusual step of addressing public fears in a televised press conference Tuesday that stressed the vaccine’s safety for those over the age of 65.

The assurances come as new information leads to an update on previous advice, which initially suggested that seniors avoid the AstraZeneca vaccine because of insufficient trial data. NACI chair Dr. Caroline Quach-Thanh says there is now enough "real-world evidence" to show it is both safe and effective for seniors.

Infectious disease doctor Zain Chagla says it's an important message, but confusing for Canadians as Germany and other European countries move to limit the vaccine's use while they investigate reports of blood clots emerging after some inoculations.

The European Medicines Agency says there is no evidence of a safety concern and is "firmly convinced" that the benefits of the AstraZeneca shot outweigh the risks.

But Chagla says unfounded doubts about efficacy and safety have been deeply sown and some people will have a hard time accepting updated advice.

Reached earlier this week as he anticipated NACI's revised guidelines, he noted the AstraZeneca product has been hit especially hard in recent weeks, on multiple fronts.

“Even if all of the dust settles on all of this stuff and it's (proven) effective in 65-year-olds and it's actually 80 per cent effective and there's no clot risk, you've already introduced three strikes that are hard to wash away from people who are already hesitant to take this vaccine over Moderna and Pfizer," Chagla, a specialist at St. Joseph's Healthcare Hamilton.

Chagla said it’s up to NACI, Health Canada, and the various provincial health ministries to be transparent and clear on the evidence.

"This needs to be aggressively put out and people need to be really, really, really transparent, open and honest about this."

MORE National ARTICLES

SFU reports data breach through cyberattack

SFU reports data breach through cyberattack
The university says the breach mostly involved student or employee identification numbers and at least one other data element, such as admission or academic standing.

SFU reports data breach through cyberattack

Man found dead in his Clayton Heights home: IHIT

Man found dead in his Clayton Heights home: IHIT
The last time Golofit made contact with friends was around 8 a.m. on February 11, 2021. Investigators will be working to build a timeline of Golofit’s activities from that point forward.

Man found dead in his Clayton Heights home: IHIT

StatCan report details dig into jobs-data leak

StatCan report details dig into jobs-data leak
The report, dated June 5 but being made public today, doesn't say how the details on the historic job losses in April made it into a media report before the agency officially released it.

StatCan report details dig into jobs-data leak

Trudeau insists Canada's vaccine supply is secure

Trudeau insists Canada's vaccine supply is secure
Moderna has confirmed delivery of another 168,000 doses next week, with 1.3 million to follow in March.

Trudeau insists Canada's vaccine supply is secure

Vancouver mayor to pursue handgun ban

Vancouver mayor to pursue handgun ban
The proposed legislation would allow municipalities to ban the weapons through bylaws restricting their possession, storage and transportation.

Vancouver mayor to pursue handgun ban

Vaccine influx to test provinces' COVID promises

Vaccine influx to test provinces' COVID promises
Regional outbreaks, emerging variants and a gradual reopening in various parts of the country have added pressure on provinces tasked with rectifying delays blamed primarily on slowed shipments from overseas manufacturers.

Vaccine influx to test provinces' COVID promises